glp-1 market news november 2025 Overview Canada GLP-1 Agonists Weight Loss

What is the key research question

G.WoodwardD

those on GLP-1s find that it helps with constipation in particular

Collectively, the majority of these analyses have not revealed evidence for increased risk 79 , 80 , 81 , 82 , 83 and some studies suggest the possibility of reduced risk of suicidal ideation or behavior

A patient may be a candidate for GLP-1 weight loss if they have obesity, overweight with weight-related health concerns, insulin resistance, prediabetes, type 2 diabetes risk, high blood pressure, high cholesterol, fatty liver concerns, sleep apnea risk, or repeated difficulty losing and maintaining weight with lifestyle changes alone